← All trials
NCT03356964
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 23, 2017
- Primary completion
- Jan 31, 2019
- Completion date
- Feb 28, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- IVI Middle East ClinicLead sponsor
- Merck SeronoCollaborator
- IVI Middle East ClinicReponsible party - principal investigator
- IVI Middle East ClinicOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.